449 related articles for article (PubMed ID: 24629722)
1. [Prophylaxis for stress ulcer bleeding in the intensive care unit].
Avendaño-Reyes JM; Jaramillo-Ramírez H
Rev Gastroenterol Mex; 2014; 79(1):50-5. PubMed ID: 24629722
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis: stress ulcer bleeding prophylaxis with proton pump inhibitors, H2 receptor antagonists.
Barkun AN; Adam V; Martel M; Bardou M
Value Health; 2013; 16(1):14-22. PubMed ID: 23337211
[TBL] [Abstract][Full Text] [Related]
3. Stress-related mucosal disease: risk factors and prophylactic therapy.
Spirt MJ
Clin Ther; 2004 Feb; 26(2):197-213. PubMed ID: 15038943
[TBL] [Abstract][Full Text] [Related]
4. Prevention and treatment of stress ulcers in critically ill patients.
Yang YX; Lewis JD
Semin Gastrointest Dis; 2003 Jan; 14(1):11-9. PubMed ID: 12610850
[TBL] [Abstract][Full Text] [Related]
5. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
[TBL] [Abstract][Full Text] [Related]
7. Preventing the gastrointestinal consequences of stress-related mucosal disease.
Metz DC
Curr Med Res Opin; 2005 Jan; 21(1):11-8. PubMed ID: 15881471
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.
Alhazzani W; Alenezi F; Jaeschke RZ; Moayyedi P; Cook DJ
Crit Care Med; 2013 Mar; 41(3):693-705. PubMed ID: 23318494
[TBL] [Abstract][Full Text] [Related]
9. Stress-induced ulcer bleeding in critically ill patients.
Ali T; Harty RF
Gastroenterol Clin North Am; 2009 Jun; 38(2):245-65. PubMed ID: 19446257
[TBL] [Abstract][Full Text] [Related]
10. Prevention of gastrointestinal bleeding due to stress ulceration: a review of current literature.
Pilkington KB; Wagstaff MJ; Greenwood JE
Anaesth Intensive Care; 2012 Mar; 40(2):253-9. PubMed ID: 22417019
[TBL] [Abstract][Full Text] [Related]
11. Benefit of an electronic medical record-based alarm in the optimization of stress ulcer prophylaxis.
Saad EJ; Bedini M; Becerra AF; Martini GD; Gonzalez JG; Bolomo A; Castellani L; Quiroga S; Morales C; Leathers J; Balderramo D; Albertini RA
Gastroenterol Hepatol; 2018; 41(7):432-439. PubMed ID: 29895412
[TBL] [Abstract][Full Text] [Related]
12. [Bleeding and pneumonia in intensive care unit patients given proton pump inhibitor or histamine-2 receptor antagonist for prevention of stress ulcer: a Meta analysis].
Zhou JF; Wan XY; Huang W; Han LL
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Apr; 22(4):221-5. PubMed ID: 20398466
[TBL] [Abstract][Full Text] [Related]
13. Stress ulcer prophylaxis with proton pump inhibitors or histamin-2 receptor antagonists in adult intensive care patients: a systematic review with meta-analysis and trial sequential analysis.
Barbateskovic M; Marker S; Granholm A; Anthon CT; Krag M; Jakobsen JC; Perner A; Wetterslev J; Møller MH
Intensive Care Med; 2019 Feb; 45(2):143-158. PubMed ID: 30680444
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness of Histamine
Hammond DA; Kathe N; Shah A; Martin BC
Pharmacotherapy; 2017 Jan; 37(1):43-53. PubMed ID: 27809338
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis.
Barkun AN; Bardou M; Pham CQ; Martel M
Am J Gastroenterol; 2012 Apr; 107(4):507-20; quiz 521. PubMed ID: 22290403
[TBL] [Abstract][Full Text] [Related]
16. A cluster randomised, crossover, registry-embedded clinical trial of proton pump inhibitors versus histamine-2 receptor blockers for ulcer prophylaxis therapy in the intensive care unit (PEPTIC study): study protocol.
Young PJ; Bagshaw SM; Forbes A; Nichol A; Wright SE; Bellomo R; Bailey MJ; Beasley RW; Eastwood GM; Festa M; Gattas D; van Haren F; Litton E; Mouncey PR; Navarra L; Pilcher D; Mackle DM; McArthur CJ; McGuinness SP; Saxena MK; Webb S; Rowan KM;
Crit Care Resusc; 2018 Sep; 20(3):182-189. PubMed ID: 30153780
[TBL] [Abstract][Full Text] [Related]
17. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: systematic review and network meta-analysis.
Wang Y; Ye Z; Ge L; Siemieniuk RAC; Wang X; Wang Y; Hou L; Ma Z; Agoritsas T; Vandvik PO; Perner A; Møller MH; Guyatt GH; Liu L
BMJ; 2020 Jan; 368():l6744. PubMed ID: 31907166
[TBL] [Abstract][Full Text] [Related]
19. When should stress ulcer prophylaxis be used in the ICU?
Quenot JP; Thiery N; Barbar S
Curr Opin Crit Care; 2009 Apr; 15(2):139-43. PubMed ID: 19578324
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials.
Alshamsi F; Belley-Cote E; Cook D; Almenawer SA; Alqahtani Z; Perri D; Thabane L; Al-Omari A; Lewis K; Guyatt G; Alhazzani W
Crit Care; 2016 May; 20(1):120. PubMed ID: 27142116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
